Travere Therapeutics: Filspari Is Becoming A Rare Kidney Disease Platform

Travere Therapeutics has transitioned into a rare disease commercial platform, driven by FILSPARI’s growth in IgAN and recent FSGS approval. More on TVTX stock.
The College Fix

U. Dallas becomes first in nation to grant credit for Classical Baccalaureate, alternative to AP

The University of Dallas has become the first school in the nation to award academic credit through the Classical ...

Dianthus Therapeutics, Inc.: Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis

EMERGE is a global, randomized, multicenter, placebo-controlled Phase 3 trial that will evaluate claseprubart 300mg/2mL S.C. dosed Q2W and Q4W vs. placebo, with top-line results anticipated in 2H'28 ...
TMCnet

Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis

Advancing a neuromuscular franchise with claseprubart, a highly potent investigational classical pathway inhibitor, across generalized Myasthenia Gravis (gMG), Multifocal Motor Neuropathy (MMN) and ...

Omeros Corporation Announces Update on European Marketing Authorization Application for Narsoplimab in TA-TMA

Omeros Corporation (Nasdaq: OMER) announced today an update on the review by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) of the company’s marketing ...

The landscapes behind the story: How Monita Bharadwaj designs became part of Imtiaz Ali's cinematic world

When filmmaker Imtiaz Ali creates a world on screen, every detail matters. From the emotions of his characters to the spaces ...
RMD Open

Emerging treatments for Sjögren’s disease: promising drugs on the horizon

Sjögren’s disease (SjD) is a chronic, multisystem autoimmune disorder characterised by lymphocytic infiltration of exocrine ...
MarketersMEDIA Newsroom

Creative Biolabs Empowers Researchers to Overcome Hurdles in Complement Drug Development

Creative Biolabs has expanded its complement testing capabilities to help researchers overcome challenges in complement drug development through comprehensive complement activity assays, CH50 ...
USA Today

Music Pathway Choir Presents Musical Theater Concert at The DiMenna Center for Classical Music

Founder Alicia Liu Continues to Build a Performance-Oriented Adult Music Community in New York. New York, NY, United States, June 18, 2026 — Music Pathway Choir presented a musical-theater-themed ...

Why is Dianthus Therapeutics stock trading higher on Friday?

Dianthus Therapeutics Inc. DNTH reported stronger-than-expected midstage results from its CAPTIVATE Phase 3 trial of claseprubart (DNTH103) in chronic inflammatory demyelinating polyneuropathy (CIDP).

Sanofi: Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy

Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy Paris, June 10, 2026. Sanofi today announced that the riliprubart MOBILIZE phase ...
Frontiers

Serum complement system activation in normal healing and atrophic non-union of human long bone fractures

The complement system has an important role in physiological bone healing, as studied mainly in animal models and local bone tissues. However, the role of the complement system in human fractures, ...